{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:41:28Z","timestamp":1794591688390,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13680-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:39:53Z","timestamp":1780069193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of procalcitonin levels with multidrug-resistant bloodstream infections: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-5278","authenticated-orcid":false,"given":"Durga Shankar","family":"Meena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Krishana","family":"Bohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manika","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naman","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Midha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhor","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Rohila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithu","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"13680_CR1","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.lansea.2024.100412","volume":"26","author":"J Kaur","year":"2024","unstructured":"Kaur J, Singh H, Sethi T. Emerging trends in antimicrobial resistance in bloodstream infections: multicentric longitudinal study in India (2017\u20132022). Lancet Reg Health Southeast Asia. 2024;26:100412.","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"10219","key":"13680_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"6","key":"13680_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.chest.2021.12.673","volume":"161","author":"NE Hammond","year":"2022","unstructured":"Hammond NE, Kumar A, Kaur P, Tirupakuzhi Vijayaraghavan BK, Ghosh A, Grattan S, et al. Sepsis in India Prevalence Study (SIPS) Investigator Network. Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study. Chest. 2022;161(6):1543\u201354.","journal-title":"Chest"},{"issue":"3","key":"13680_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/microorganisms8030346","volume":"8","author":"T \u0179r\u00f3d\u0142owski","year":"2020","unstructured":"\u0179r\u00f3d\u0142owski T, Sobo\u0144ska J, Salamon D, McFarlane IM, Zi\u0119tkiewicz M, Gosiewski T. Classical Microbiological Diagnostics of Bacteremia: Are the Negative Results Really Negative? What is the Laboratory Result Telling Us About the Gold Standard? Microorganisms. 2020;8(3):346.","journal-title":"Microorganisms"},{"issue":"2","key":"13680_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/10408363.2021.1988047","volume":"59","author":"HG Xu","year":"2022","unstructured":"Xu HG, Tian M, Pan SY. Clinical utility of procalcitonin and its association with pathogenic microorganisms. Crit Rev Clin Lab Sci. 2022;59(2):93\u2013111.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"13680_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","volume":"5","author":"AL Vijayan","year":"2017","unstructured":"Vijayan AL, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.","journal-title":"J Intensive Care"},{"issue":"2","key":"13680_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206\u201317.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13680_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","volume":"22","author":"DO Thomas-R\u00fcddel","year":"2018","unstructured":"Thomas-R\u00fcddel DO, Poidinger B, Kott M, Weiss M, Reinhart K, Bloos F, MEDUSA study group. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care. 2018;22(1):128.","journal-title":"Crit Care"},{"issue":"1","key":"13680_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jiph.2019.06.003","volume":"13","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D\u2019Aurizio F, Sartor A, Curcio F. Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience. J Infect Public Health. 2020;13(1):40\u20135.","journal-title":"J Infect Public Health"},{"key":"13680_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/IJGM.S115277","volume":"9","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Oikawa N, Hariu M, Fuke R, Seki M. Ability of procalcitonin to diagnose bacterial infection and bacteria types compared with blood culture findings. Int J Gen Med. 2016;9:325\u201331.","journal-title":"Int J Gen Med"},{"issue":"7","key":"13680_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.21037\/atm.2019.03.24","volume":"7","author":"Y Leng","year":"2019","unstructured":"Leng Y, Chen C, Zhang Y, Luo C, Liu B. Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection. Ann Transl Med. 2019;7(7):135.","journal-title":"Ann Transl Med"},{"issue":"1","key":"13680_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.burns.2019.04.010","volume":"46","author":"JC Lin","year":"2020","unstructured":"Lin JC, Chen ZH, Chen XD. Elevated serum procalcitonin predicts Gram-negative bloodstream infections in patients with burns. Burns. 2020;46(1):182\u20139.","journal-title":"Burns"},{"key":"13680_CR13","doi-asserted-by":"publisher","first-page":"q1173","DOI":"10.1136\/bmj.q1173","volume":"385","author":"A Gildea","year":"2024","unstructured":"Gildea A, Mulvihill C, McFarlane E, Gray A, Singer M. guideline committee. Recognition, diagnosis, and early management of suspected sepsis: summary of updated NICE guidance. BMJ. 2024;385:q1173.","journal-title":"BMJ"},{"issue":"3","key":"13680_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"13680_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccc.2019.08.003","volume":"36","author":"B Hamade","year":"2020","unstructured":"Hamade B, Huang DT. Procalcitonin: Where Are We Now? Crit Care Clin. 2020;36(1):23\u201340.","journal-title":"Crit Care Clin"},{"issue":"1","key":"13680_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13054-023-04677-2","volume":"27","author":"M Papp","year":"2023","unstructured":"Papp M, Kiss N, Baka M, Tr\u00e1sy D, Zubek L, Feh\u00e9rv\u00e1ri P, Harnos A, Turan C, Hegyi P, Moln\u00e1r Z. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis. Crit Care. 2023;27(1):394.","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"13680_CR17","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ijantimicag.2015.10.012","volume":"46","author":"N Br\u00e9chot","year":"2015","unstructured":"Br\u00e9chot N, H\u00e9kimian G, Chastre J, Luyt CE. Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents. 2015;46(Suppl 1):S19\u201324.","journal-title":"Int J Antimicrob Agents"},{"key":"13680_CR18","unstructured":"Khilnani GC, Tiwari P, Zirpe KG, Chaudhry D, Govil D, Dixit S, Kulkarni AP, Todi SK, Hadda V, Jain N, Govindagoudar MB, Samavedam S, Jha SK, Tyagi N, Jaju MR, Sharma A. Guidelines for the use of procalcitonin for rational use of antibiotics. Indian J Crit Care Med."},{"issue":"1","key":"13680_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95\u2013107.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13680_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13613-017-0338-6","volume":"7","author":"HB Huang","year":"2017","unstructured":"Huang HB, Peng JM, Weng L, Wang CY, Jiang W, Du B. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):114.","journal-title":"Ann Intensive Care"},{"key":"13680_CR21","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3389\/fmicb.2018.02047","volume":"9","author":"HF Pe\u00f1aloza","year":"2018","unstructured":"Pe\u00f1aloza HF, Noguera LP, Riedel CA, Bueno SM. Expanding the Current Knowledge About the Role of Interleukin-10 to Major Concerning Bacteria. Front Microbiol. 2018;9:2047.","journal-title":"Front Microbiol"},{"issue":"8","key":"13680_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/pathogens12081044","volume":"12","author":"G Schinas","year":"2023","unstructured":"Schinas G, Skintzi K, De Lastic AL, Rodi M, Gogos C, Mouzaki A, Akinosoglou K. Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study. Pathogens. 2023;12(8):1044.","journal-title":"Pathogens"},{"issue":"2","key":"13680_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/IAI.72.2.788-794.2004","volume":"72","author":"J Branger","year":"2004","unstructured":"Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004;72(2):788\u201394.","journal-title":"Infect Immun"},{"key":"13680_CR24","doi-asserted-by":"publisher","first-page":"701480","DOI":"10.1155\/2015\/701480","volume":"2015","author":"C Leli","year":"2015","unstructured":"Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480.","journal-title":"Dis Markers"},{"issue":"4","key":"13680_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","volume":"11","author":"O Takeuchi","year":"1999","unstructured":"Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11(4):443\u201351.","journal-title":"Immunity"},{"key":"13680_CR26","doi-asserted-by":"crossref","unstructured":"Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H. Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Crit Care. 2010.","DOI":"10.1186\/cc8898"},{"key":"13680_CR27","doi-asserted-by":"publisher","first-page":"1043968","DOI":"10.3389\/fimmu.2022.1043968","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li B, Ning B, Evaluating. IL-6 and IL-10 as rapid diagnostic tools for Gram-negative bacteria and as disease severity predictors in pediatric sepsis patients in the intensive care unit. Front Immunol. 2022;13:1043968.","journal-title":"Front Immunol"},{"issue":"4","key":"13680_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajem.2016.12.017","volume":"35","author":"ST Yan","year":"2017","unstructured":"Yan ST, Sun LC, Jia HB, Gao W, Yang JP, Zhang GQ. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35(4):579\u201383.","journal-title":"Am J Emerg Med"},{"issue":"8","key":"13680_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/0972-5229.162466","volume":"19","author":"V Mishra","year":"2015","unstructured":"Mishra V, Sorabjee J. Procalcitonin levels in salmonella infection. Indian J Crit Care Med. 2015;19(8):471\u20133.","journal-title":"Indian J Crit Care Med"},{"key":"13680_CR30","doi-asserted-by":"publisher","first-page":"e1002933","DOI":"10.1371\/journal.ppat.1002933","volume":"8","author":"HK Jong","year":"2012","unstructured":"Jong HK, Parry CM, van der Poll T, Wiersinga WJ. Host-pathogen interaction in invasive salmonellosis. PLoS Pathog. 2012;8:e1002933.","journal-title":"PLoS Pathog"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13680-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:14:21Z","timestamp":1785752061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13680-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13680"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13680-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Institutional ethics committee, AIIMS Jodhpur (Reference no: AIIMS\/IEC\/2022\/3923).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient included in this report.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1417"}}